Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.
about
The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.Anti-Platelet Factor 4/Heparin Antibody Plays a Significant Role in Progression of Arterial Stiffness among Hemodialysis Patients.
P2860
Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@ast
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@en
type
label
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@ast
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@en
prefLabel
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@ast
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@en
P2093
P2860
P1476
Anti-PF4/heparin antibodies ar ...... iabetic hemodialysis patients.
@en
P2093
Chien-An Chen
Kao-Chang Lin
Yueh-Feng Tsai
P2860
P2888
P304
P356
10.1007/S10157-011-0555-5
P577
2011-11-01T00:00:00Z